We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

February 26, 2021

“These are interventions that actually work” Brian Dolan

Reports
Ian Matthews
&

This month’s Digital Health Videocast sees us sit down with Brian Dolan, Founder and lead writer of Exits & Outcomes (E&O), following the highly successful launch of our latest industry report Prescription Digital Therapeutics (PDT) The Future of Digital Therapeuticsco-created by HealthXL and E&O.


For those of you following our videocast series, there may be a sense of déjà vu as we learn of Brian’s early career connection with Washington DC (much like our previous sit-downs with Sarah Iselin, Chris Coburn and Steve Kraus). Having attended Boston University and taking advantage of their excellent journalism school Brian was to find himself placed in Washington DC as a political correspondent for a semester. A career as a political journalist was not on the cards but Washington had captivated him. On graduating from Boston University Brian moved to the nation’s capital permanently as an editor for the media brand Fierce Markets. It was during his tenure here in which he was exposed to both technology and healthcare publications, helping to launch a series of publications focused on mobile in the mid-2000s. 


We learn of his passion as he watched the mobile industry evolve out of nothing, indeed an industry that would be paramount to the evolution of healthcare. On seeing mobile solutions being adopted across industries Brian felt there was ample opportunity to integrate it with the healthcare industry who had not fully embraced it yet and so in 2008 MobiHealthNews was born as a health tech publication.


Brian’s understanding of the fusion and possibilities between technology and healthcare has evolved over the past decade as the industry moved from the early days of med-tech to what we know now as digital health. 


Digital health has come to mean so many things” Brian tells us and it is perhaps for this reason he founded Exits & Outcomes in 2019. “Digital health has matured considerably in the past 12 years since I first started writing about it, but most health tech journalism is still written for those just entering the discussion. Exits & Outcomes (E&O) is a subscription-only, weekly newsletter for digital health strategists, creatives, and operators.”


It is Brian's experience in this industry that makes him such a valuable collaborator on our latest industry report. HealthXL released our first industry report on Digital Therapeutics (DTx) back in 2018 but so much has changed since then. A wide variety of companies have co-opted the term “digital therapeutics'' to describe their digital health offerings. We discuss our collaboration on the report which seeks to cut through some of that noise by focusing on a smaller promising subset of this group: prescription digital therapeutics.


A key part of our conversation turns to how we may define DTx with Brian summing up “The key to it is (DTx) are not just interventions but they have some sort of evidence to back them up...These are interventions that actually work”.


During the videocast we dive into a number of areas including:


What does the future of DTx look like to you. ? Get in touch with us here!

HealthXL Executive members can access the report for free on the Community Hub. If you are not an Executive member yet, you can access an 11-page snapshot for free here.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Not yet a member of HealthXL? Download your 11 page snapshot of the report.

Download your 11 page snapshot

Connect with peers and share insights

Don't miss out on the discussion of the latest insights and reports on digital health. Meet with peers and take a deep dive for 75 minutes. Unlike at webinars, you can freely exchange experiences and insights to solve challenges and design the future of DTx.

Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

What are the best routes to market in DTx?

12th April @ 11:00am EDT

Join us as we discuss what are the most scalable and sustainable routes to market in DTx. Great opportunity to connect with peers and meet new people.

Featuring
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Robert Stern
Robert Stern
Founder & CEO, At Point Of Care
Featuring
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Robert Stern
Robert Stern
Founder & CEO, At Point Of Care
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

Masterclass - The regulation of DTx

15th April @ 10:30am EDT

Join us in this Masterclass led by Stephen Gibney from BlueBridge Technologies as we discuss the regulation of DTx. Great opportunity to Listen, engage and most importantly, enjoy.

Featuring
Stephen Gibney
Stephen Gibney
Quality Assurance Manager at BlueBridge Technologies
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Featuring
Stephen Gibney
Stephen Gibney
Quality Assurance Manager at BlueBridge Technologies
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

Why is Medtech right for DTx and vice versa

22nd April @ 11:30am EDT

Join our Digital Health Meeting as we discuss why Medtech is right for DTx and vice versa. Apply promptly to get involved in the conversation, network with peers and share your thoughts on the topic.

Featuring
Lisa Suennen
Lisa Suennen
Group Leader, Manatt Ventures
Vivian Emmely de Ruijter
Vivian Emmely de Ruijter
Senior Manager, Digital and Technology Group, Manatt Ventures at Manatt, Phelps & Phillips, LLP
Featuring
Lisa Suennen
Lisa Suennen
Group Leader, Manatt Ventures
Vivian Emmely de Ruijter
Vivian Emmely de Ruijter
Senior Manager, Digital and Technology Group, Manatt Ventures at Manatt, Phelps & Phillips, LLP
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

DTx - Overview of market and deals

28th April @ 10:30AM EDT

Join our Digital Health Meeting focused on the overview of market and deals in the DTx industry. Apply promptly to secure your place in the discussion and network with peers.

Featuring
Ethan Wergelis-Isaacson
Ethan Wergelis-Isaacson
Digital Health Strategy & Business Development , Otsuka Pharmaceutical Companies
Featuring
Ethan Wergelis-Isaacson
Ethan Wergelis-Isaacson
Digital Health Strategy & Business Development , Otsuka Pharmaceutical Companies

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

What are the best routes to market in DTx?

12th April @ 11:00am EDT

Join us as we discuss what are the most scalable and sustainable routes to market in DTx. Great opportunity to connect with peers and meet new people.

Featuring
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Robert Stern
Robert Stern
Founder & CEO, At Point Of Care
Featuring
Rick Bartels
Rick Bartels
Managing Partner , DTxCC
Robert Stern
Robert Stern
Founder & CEO, At Point Of Care
Clinician and Patient Engagement & Support
Clinician and Patient Engagement & Support
Clinician and Patient Engagement & Support
Clinician and Patient Engagement & Support

The future of digital medical education

13th April @ 10:30am EDT

Join us as we discuss the future of digital medical education and its impact on digital health adoption. Great opportunity to connect with peers, engage in thought-provoking conversations and meet new people.

Featuring
Joshua Landy MD
Joshua Landy MD
Chief Medical Officer, Figure 1
Meg Barron
Meg Barron
Vice President, Digital Health Strategy, American Medical Association
Featuring
Joshua Landy MD
Joshua Landy MD
Chief Medical Officer, Figure 1
Meg Barron
Meg Barron
Vice President, Digital Health Strategy, American Medical Association
Clinician and Patient Engagement & Support
Clinician and Patient Engagement & Support
Clinician and Patient Engagement & Support
Clinician and Patient Engagement & Support

Role of digital patient communities in 2021

14th April @ 10:30am EDT

Join our Digital Health Meeting as we discuss the role of digital patient communities in 2021. Apply now to secure your place in the conversation and gain valuable insights from thought leaders in the industry.

Featuring
Chelsea Pan
Chelsea Pan
Partnership Engagement Manager, Verily Life Sciences
Carlos Rodarte
Carlos Rodarte
Founder & Managing Director, Volar Health LLC
Featuring
Chelsea Pan
Chelsea Pan
Partnership Engagement Manager, Verily Life Sciences
Carlos Rodarte
Carlos Rodarte
Founder & Managing Director, Volar Health LLC
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)
Digital Therapeutics (DTX)

Masterclass - The regulation of DTx

15th April @ 10:30am EDT

Join us in this Masterclass led by Stephen Gibney from BlueBridge Technologies as we discuss the regulation of DTx. Great opportunity to Listen, engage and most importantly, enjoy.

Featuring
Stephen Gibney
Stephen Gibney
Quality Assurance Manager at BlueBridge Technologies
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.
Featuring
Stephen Gibney
Stephen Gibney
Quality Assurance Manager at BlueBridge Technologies
Jordan Silberman, MD, PhD
Jordan Silberman, MD, PhD
Director of Clinical Analytics and Research, Digital Care Delivery, Anthem, Inc.

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.